Please login to the form below

Not currently logged in


This page shows the latest Nanobiotix news and features for those working in and with pharma, biotech and healthcare.

Positive data unlocks more EIB funding for Nanobiotix

Positive data unlocks more EIB funding for Nanobiotix

French biotech Nanobiotix has received a second 14m tranche from a European Investment Bank (EIB) loan, triggered by meeting two development objectives. ... Nanobiotix has previously received 16m from the EIB and can draw on the final 10m by July 2020.

Latest news

  • Nanobiotix signs €40m deal with the EIB Nanobiotix signs €40m deal with the EIB

    loan to fund innovative nanomedicine platform. France's nanomedicine specialist Nanobiotix has secured 40m from the European Investment Bank (EIB) to fund its research. ... Philippe Mauberna, chief financial officer of Nanobiotix, said: “This loan will

  • Lilly closes on first approval for sarcoma drug Lartruvo Lilly closes on first approval for sarcoma drug Lartruvo

    Meanwhile, Nanobiotix filed for approval of its radio-enhancer drug NBTXR3 for STS in Europe last week, while CytRx has an improved doxorubicin candidate called aldoxorubicin in late-stage testing.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Nanobiotix strengthens US leadership team Nanobiotix strengthens US leadership team

    Dr Obrocea (pictured right) joins Nanobiotix as head of US clinical development, bringing 20 years of clinical research leadership to the role. ... Meanwhile, Kurdi (pictured left) becomes director of investor relations at Nanobiotix, moving from the

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Behavioural Science in Healthcare
Personal health and wellbeing has never been more a part of the public conscious than it is now....
Why aren't doctors using digital therapeutics?
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...
Dec PME cover
Creativity in storytelling: why pharma must invest more in creativity
Chris Ross explores the value, the art and the much-rumoured death of creativity...